Cardlytics (NASDAQ:CDLX) Earns Hold Rating from Needham & Company LLC

Cardlytics (NASDAQ:CDLX)‘s stock had its “hold” rating restated by analysts at Needham & Company LLC in a research note issued on Thursday,Benzinga reports.

Cardlytics Stock Down 2.0 %

CDLX stock opened at $1.98 on Thursday. The company’s 50 day simple moving average is $3.09 and its 200-day simple moving average is $3.52. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. Cardlytics has a 52-week low of $1.77 and a 52-week high of $20.52. The firm has a market capitalization of $100.63 million, a P/E ratio of -0.32 and a beta of 1.62.

Insiders Place Their Bets

In other Cardlytics news, CFO Alexis Desieno sold 8,854 shares of the company’s stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $3.67, for a total value of $32,494.18. Following the transaction, the chief financial officer now directly owns 121,976 shares of the company’s stock, valued at $447,651.92. This represents a 6.77 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction that occurred on Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the completion of the sale, the chief executive officer now owns 215,494 shares of the company’s stock, valued at $844,736.48. This trade represents a 6.57 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 111,454 shares of company stock worth $391,864. 4.40% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cardlytics

Institutional investors have recently modified their holdings of the company. GSA Capital Partners LLP increased its stake in shares of Cardlytics by 1,273.2% in the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after purchasing an additional 354,474 shares during the period. RBF Capital LLC increased its stake in Cardlytics by 311.9% in the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock valued at $1,562,000 after acquiring an additional 369,620 shares during the period. Geode Capital Management LLC raised its holdings in shares of Cardlytics by 7.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock worth $3,371,000 after buying an additional 73,484 shares in the last quarter. Barclays PLC boosted its stake in shares of Cardlytics by 223.9% in the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock worth $72,000 after buying an additional 5,392 shares during the last quarter. Institutional investors own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.